$479M Philips Respironics CPAP Recall Settlement (Closed)

$479M Philips Respironics CPAP, BiPAP, and ventilator recall class action settlement

Published: February 5, 2024 · Updated: June 18, 2026

Status Closed · Payments Distributing economic-loss claim deadline (Aug 9, 2024) has passed

Settlement Fund $479 million+ economic-loss settlement · separate $1.1B personal-injury settlement

Devices CPAP · BiPAP · ventilators ~10.8 million recalled Philips Respironics devices

Can I Still Claim? No — deadline passed new claims are no longer accepted

What Was the Philips Respironics Devices Settlement?

Philips Respironics, a medical-supply company owned by Philips, agreed to pay a minimum total of $479 million to compensate eligible consumers who paid for certain CPAP, BiPAP, and ventilator devices used for sleep apnea and breathing support. The settlement also included up to $15 million for "Device Replacement Awards" and $34 million for "Payer Awards." This was an economic-loss settlement only.

Approximately 10.8 million Continuous Positive Airway Pressure (CPAP) devices, Bi-Level Positive Airway Pressure (BiPAP) devices, ventilators, and other devices sold or distributed in the United States by Philips Respironics were subject to recall due to a foam defect. Philips medical devices used to treat obstructive sleep apnea and other breathing difficulties were associated with hundreds of reported deaths since April 2021, based on reporting from the U.S. Food and Drug Administration.

This settlement resolved economic-loss claims stemming from the purchase of affected Philips devices. It did not include claims for personal injury or medical monitoring, which were litigated and resolved separately (see below). Anyone using one of these devices should not stop treatment without consulting their physician.

Who Qualified for a Payout?

You were a member of the Settlement Class if you were a person residing in the United States (including its Territories and the District of Columbia) who paid for, rented or leased, was prescribed, or reimbursed a payment for a qualifying recalled device. This included insurers, self-funded employers, and third-party payers. There were four categories of awards:

• Device Payment Award — for consumers who did not return their recalled device to Philips Respironics.
• Device Return Award — for consumers who registered and intended to return their recalled device.
• Device Replacement Award — for consumers who used their own money to purchase, lease, or rent a comparable replacement device.
• Payer Award — for those who reimbursed (in whole or in part) a payment for a recalled device.

Devices that had already been replaced by Philips were not eligible, even if the serial number otherwise appeared eligible.

Device Payment Award Amounts

Qualifying class members were eligible for a Device Payment Award for each recalled device they purchased, leased, or rented. The amount depended on the device model:

Recalled Device	Device Payment Award (Per Device)
System One 50 Series ASV4 (Auto SV4)	$469.14
System One 50 Series Base	$69.14
System One 50 Series BiPAP	$159.46
System One 60 Series ASV4 (Auto SV4)	$424.32
System One 60 Series Base	$68.24
System One 60 Series BiPAP	$152.70
C-series S/T, AVAPS (C-series and C-series HT)	$394.37
DreamStation CPAP	$55.63
DreamStation ASV	$379.50
DreamStation ST, AVAPS	$329.05
DreamStation BiPAP	$130.63
DreamStation Go	$107.43
E30	$453.83
OmniLab Advanced Plus	$165.99
Trilogy 100/200, Garbin Plus, Aeris LifeVent	$1,552.25
V30 auto	$67.12

Class members could also qualify for a $100 Device Return Award for each recalled device returned, a Device Replacement Award for money spent to replace a recalled device on or after June 14, 2021 and before September 7, 2023, and a Payer Award from the $34 million payer fund.

The Claim Deadline Has Passed

The deadline to file an economic-loss claim was August 9, 2024, and the settlement is now closed to new claims. Approved claims have been processed and payments are being distributed. There is nothing left to file for the economic-loss settlement.

What About Personal-Injury Claims?

Personal-injury and medical-monitoring claims were handled separately from this economic-loss settlement. Philips reached a separate $1.1 billion personal-injury settlement in 2024. That program's registration deadline (January 31, 2025) and claim deadline (March 7, 2026) have also passed, and those claims are no longer being accepted. Payments on approved personal-injury claims began in 2026.

Frequently Asked Questions

Is the Philips Respironics settlement still open?

No. The economic-loss settlement claim deadline (August 9, 2024) has passed, and the settlement is closed to new claims. Approved claims are being processed and payments are being distributed.

What did the economic-loss settlement cover?

The $479 million economic-loss settlement compensated people who paid for, leased, rented, or were prescribed certain recalled Philips Respironics CPAP, BiPAP, and ventilator devices. It included Device Payment Awards, a $100 Device Return Award, Device Replacement Awards, and Payer Awards. It did not cover personal-injury or medical-monitoring claims.

What about personal-injury claims?

Personal-injury and medical-monitoring claims were handled separately. Philips reached a separate $1.1 billion personal-injury settlement in 2024; its registration deadline (January 31, 2025) and claim deadline (March 7, 2026) have also passed, and those claims are no longer being accepted.

Free settlement alerts

Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.